Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00603967 · ClinicalTrials.gov registry record · NA
Effect of Aromatase Inhibitors on Bones and Genes
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 151
- Enrollment target
NCT00603967: Completed NA study, sponsored by Washington University School of Medicine.
NCT00603967 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 151 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00603967, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 151 participants
- Enrollment target
Study Summary
The primary objective of this 2-year pilot project is to test the hypothesis that skeletal response to aromatase inhibitors is determined by polymorphisms of the CYP19 gene.
Interventions
- PROCEDURE Blood draw
- BEHAVIORAL Questionnaire
- PROCEDURE Dual x-ray absorptiometry (DXA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 151 participants |
| Start Date | 2006-03 |
| Est. Completion | 2009-10 |
| Phase | NA |
What the finished NCT00603967 record still lists
NCT00603967 is an interventional study that assigns participants to a tested intervention. The registered 151 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 3 interventions - of which Blood draw is the first listed.
NCT00603967 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00603967 about?
NCT00603967 is a clinical study titled "Effect of Aromatase Inhibitors on Bones and Genes". The primary objective of this 2-year pilot project is to test the hypothesis that skeletal response to aromatase inhibitors is determined by polymorphisms of the CYP19 gene.
What is the current status of trial NCT00603967?
This trial is currently completed. It is a NA study. The enrollment target is 151 participants. The study started on 2006-03. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00603967?
The interventions under investigation include: Blood draw (PROCEDURE), Questionnaire (BEHAVIORAL), Dual x-ray absorptiometry (DXA) (PROCEDURE).
Who is sponsoring clinical trial NCT00603967?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00603967's enrollment target sits among peer trials
151 661st of 2000 higher than 1,340 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01409161 · 151 participants · Phase 2
Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
- NCT04245397 · 151 participants · Phase 1
Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
- NCT05761223 · 151 participants · Phase 1
A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849
- NCT07195656 · 151 participants · NA
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia